ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000261916.1	Gefitinib	Chronic Lymphocytic Leukemia	0.019494808	Resistant
ENSG00000261916.1	Gefitinib	Bladder urothelial carcinoma	0.015581321	Sensitive